Speaker List

Type here to filter the list

Names Organization City State Country

F
JF

Faillie, Jean-Luc
Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier; INSERM, Université de Montpellier, Institut Desbrest d’Épidémiologie et de Santé Publique, Montpellier, France
France
KF

Fall, Katja
Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
Sweden
Farokhnia, Mehdi (he/him/his)
Staff Scientist, Assistant Professor
NIH, Johns Hopkins
Baltimore, United States
DF

Faurholt-Jepsen, Daniel
Department of Infectious Diseases, University Hospital of Copenhagen – Rigshospitalet, Cystic Fibrosis Centre, DK
Copenhagen, Denmark
SF

Fazio, Sergio
Regeneron Pharmaceuticals, Inc.
Tarrytown, United States
LF

Feinberg, Laurie
Acumen LLC
United States
MF

Felldin, Marie
The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
Sweden
Feng, Hui (she/her/hers)
Senior AI Scientist
IQVIA
United Kingdom
Zf

feng, Zeny
Department of Mathematics and Statistics, University of Guelph
Canada
JF

Fernandes, João Paulo
Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal
Portugal
DF

Fiellin, David
Yale School of Medicine
United States
Filion, Kristian B. (he/him/his)
Associate Professor
McGill University
Montreal, Canada
HF

Finertie, Holly
Division of Research, Kaiser Permanente Northern California, Oakland, California
United States
SF

Fisher, Shelby
RTI International
United States
JF

Fix, Jonathan (he/him/his)
Associate Director, Safety Epidemiology and Benefit Risk
Novavax
United States
RF

Flynn, Robert
pharmacoepidemiologist
European Medicines Agency, University of Dundee
Netherlands
AF

Fontana, Andrea
Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
Italy
AF

Forget, Amélie
University of Montreal
Canada
Forns, Joan
RTI Health Solutions
BARCELONA, Spain
Forshee, Richard A.
Deputy Director
Office of Biostatistics and Pharmacovigilance, CBER, US FDA
Silver Spring, United States
RF

Fortuna, Romain
EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)
France
KF

Foti, Kathryn
Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama
United States
OF

Fröbert, Ole
Department of Medical Sciences
Sweden
VF

Frajzyngier, Vera
VP Scientific Research
Aetion
United States
Franklin, Jessica M. (she/her/hers)
Principal Consultant
Optum
Marietta, United States
Franzén, Stefan (he/him/his)
Director
BPM Evidence Statistics, BioPharmaceutical Medical, AstraZeneca, Gothenburg, Sweden
Sweden
Freeman, Patricia R.
Professor
University of Kentucky College of Pharmacy
Lexington, United States
PF

Freyria Duenas, Pablo
Acumen LLC
United States
MF

Friedman, Mark
Panalgo
United States
AF

Frigessi, Arnoldo
Full professor
1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo
Norway
VF

Friman, Vanda
Assoc. Prof.
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Sweden
EF

Fu, Edouard L.
Leiden University Medical Center
Netherlands
Fuller, Candace C.
Research Scientist
Department of Population Medicine, Harvard Pilgrim Health Care Institute
Boston, United States
Fu, Mengyuan
Postdoctoral fellow
International Research Center for Medicinal Administration, Peking University
United States
KF

Fung, Kelly
Research Specialist
Brigham and Women's Hospital and Harvard Medical School
United States
Furby, Hannah V. (she/her/hers)
Principal Real World Data Scientist
Roche Product Ltd.
Welwyn Garden City, United Kingdom
Furu, Kari (she/her/hers)
Senior researcher
Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Norway